In addition, prevention for FasL/Fas interaction by administration of antagonist or functional mutation on FasL gene protects mice against lethal viral infection and prevents reduction of CD3 (+) cell population, which mediated by lethal infection with the virus in the lung. This evidence concerns the gene FASLG and viral infectious disease.